Afname van foetale en neonatale sterfte in Nederland

Vergelijking met andere Euro-Peristat-landen in 2004, 2010 en 2015
Onderzoek
06-08-2019
Lisa Broeders, Peter W. Achterberg, Adja J.M. Waelput, Anita C.J. Ravelli, Anneke Kwee, Floris Groenendaal, Pien Offerhaus, Koos van der Velden, Ageeth N. Rosman en Jan G. Nijhuis

Decrease in foetal and neonatal mortality in the Netherlands; comparison with other Euro-Peristat countries in 2004, 2010 and 2015

Objective

To compare changes in foetal, neonatal and perinatal mortality in the Netherlands in 2015, relative to 2004 and 2010, with changes in other European countries and regions.

Design

Descriptive population-wide study.

Method

Data from 32 European countries and regions within the Euro-Peristat registration area were analysed. These countries and regions were grouped into: the Netherlands, Scandinavia, Western Europe and Eastern Europe. International differences in registration and policies were taken into account by using rates from 28 weeks gestation for foetal mortality and for 24 weeks gestation and beyond for neonatal mortality. Ranking was based on individual countries and regions.

Results

Foetal mortality decreased by 24% in the Netherlands, from 2.9 per 1,000 births in 2010 to 2.2 per 1,000 births in 2015; neonatal mortality decreased by 9%, from 2.2 to 2.0 per 1,000 live births. Perinatal mortality (the sum of foetal mortality and neonatal mortality) decreased by 18% from 5.1 to 4.2 per 1,000 births. The Netherlands moved from the 18th place in the European ranking in 2004 to the 10th place in 2015.

Conclusion

Foetal, neonatal and perinatal mortality in the Netherlands decreased in 2015 when compared with 2004 and 2010. The country’s position in the European ranking also improved. Explanations for this decrease are related to changes in the areas of organisation of care, population and risk factors. When mortality rates in other European countries and regions – particularly Scandinavia – are considered there is room for further improvement.

Conflict of interest and financial support: none declared.